Consolidated Statement of Comprehensive Income

XLS

 

 

 

€ million

Q1 – 2012

Q1 – 2011

Profit after tax

176.6

344.2

Available-for-sale financial assets

 

 

Fair value adjustments

25.2

Reclassification to income statement

–4.4

Deferred taxes

0.8

Changes recognized in equity

21.6

Derivative financial instruments

 

 

Fair value adjustments

25.6

11.8

Reclassification to income statement

42.0

2.1

Deferred taxes

–10.1

–0.6

Changes recognized in equity

57.5

13.3

Actuarial gains and losses from defined benefit obligations and similar obligations

 

 

Changes in actuarial gains and losses

–1.0

Deferred taxes

Changes recognized in equity

–1.0

Exchange differences on translating foreign operations

 

 

Changes taken directly to equity

–19.4

–69.1

Reclassification to income statement

3.5

Changes recognized in equity

–19.4

–65.6

Gains/losses recognized immediately in equity

37.1

–30.7

Comprehensive income

213.8

313.5

of which attributable to Merck KGaA shareholders

211.5

312.6

of which attributable to non-controlling interest

2.3

0.9